Anti-Tumor Activity Shown By Rexin-G
May 21, 2008 · Filed Under Cancer Treatment · Comment
Epeius Biotechnologies announced the results of an on-going Phase I/II study of Rexin-G for metastatic pancreatic cancer. Continuing on with the planned dose-escalations of Rexin-G which began in 2005 using lower doses of Rexin-G in a Phase I safety study (Molecular Therapy, 2008) Read more

